Relmada Therapeutics Inc
NASDAQ:RLMD
Relmada Therapeutics Inc
NASDAQ:RLMD
Price:
6.21
USD
-3.72%
Market Closed
Market Cap:
$651.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Relmada Therapeutics Inc
NASDAQ:RLMD
|
US |
|
Albany International Corp
NYSE:AIN
|
US |
|
DHT Holdings Inc
NYSE:DHT
|
BM |
|
F
|
Fuerte Metals Corp
XTSX:FMT
|
CA |
|
New Hope Corporation Ltd
ASX:NHC
|
AU |
|
R
|
Rio Tinto Ltd
DUS:CRA1
|
AU |
|
I
|
Invesco Ltd
F:3IW
|
US |
|
T
|
Tod's SpA
LSE:0NV4
|
IT |
|
N
|
Novartis AG
XBER:NOT
|
CH |
|
Aem Holdings Ltd
OTC:AEMFF
|
SG |
|
Surgery Partners Inc
NASDAQ:SGRY
|
US |
|
I
|
IAMGOLD Corp
SWB:IAL
|
CA |
|
T
|
TRYP Therapeutics Inc
CNSX:TRYP
|
CA |
|
Manappuram Finance Ltd
BSE:531213
|
IN |
DCF Valuation
is not available for Relmada Therapeutics Inc
is not available for Relmada Therapeutics Inc
RLMD's DCF value cannot be reliably calculated.
Switch to
Continue RLMD Research
Other Relmada Therapeutics Inc listings:
Discover More
